angioplasty

BVS_everolimus

Promising Outcomes of Overlapping Stents in Patients Undergoing Bioresorbable Scaffold (BRS) Implantation

Courtesy of Dr. Guillermo Migliaro. In regular clinical practice, overlapping stents are reported in up to 30% of patients undergoing coronary angioplasty, especially due to very long lesions requiring implantation of multiple stents or dissection after the implantation of a first stent. &nbsp; In bare metal stent era, overlapping was associated with unfavorable clinical outcomes<a href="https://solaci.org/en/2017/05/08/promising-outcomes-of-overlapping-stents-in-patients-undergoing-bioresorbable-scaffold-brs-implantation/" title="Read more" >...</a>

Promising outcomes for DEB in long femoropopliteal artery lesions

Courtesy of Dr. Carlos&nbsp;Fava. For type&nbsp;A and B femoropopliteal artery lesions, percutaneous transluminal angioplasty (PTA) with balloon has proven beneficial; however, drug-eluting balloons (DEB) have shown superiority as regards restenosis. &nbsp; Some studies have reported favorable outcomes for DEB in type&nbsp;C and D lesions, but its real benefit is still unclear. &nbsp; This study prospectively<a href="https://solaci.org/en/2017/04/24/promising-outcomes-for-deb-in-long-femoropopliteal-artery-lesions/" title="Read more" >...</a>

Stent directo vs angioplastia convencional y sus interacciones con la trombo-aspiración

Bioresorbable scaffolds with drug-eluting stents: do they entail a higher thrombosis risk?

Courtesy of Dr. Leiva. Bioresorbable scaffolds with drug-eluting stents (bioresorbable vascular scaffolds, BVS) have been added to the list of endovascular treatment options for coronary disease. The ABSORB III trial showed the non-inferiority of this stent type to everolimus-eluting metallic stents as regards target-lesion revascularization (TLR) at one year. However, reports have suggested a higher<a href="https://solaci.org/en/2017/04/21/bioresorbable-scaffolds-with-drug-eluting-stents-do-they-entail-a-higher-thrombosis-risk/" title="Read more" >...</a>

ffr para guiar revascularizacion en SCA

FFR-Guided ACS Revascularization Apparently Superior to Culprit Vessel Treatment

Using fractional flow reserve (FFR) to guide revascularization of all functionally significant lesions in the setting of acute coronary syndrome appears to improve outcomes over treating only the culprit artery, according to the Compare-Acute trial. &nbsp; This study, conducted at 24&nbsp;centers in Europe and Asia, enrolled 885&nbsp;patients who were stable following successful primary angioplasty and<a href="https://solaci.org/en/2017/04/11/ffr-guided-acs-revascularization-apparently-superior-to-culprit-vessel-treatment/" title="Read more" >...</a>

recanalizacion cto

DECISION-CTO: Prevailing Questions on CTO Rechanneling

The first and only randomized trial on chronic total occlusion (CTO) revascularization versus optimal medical therapy in stable patients has disappointed interventional cardiologists. &nbsp; According to Dr. Seung-Jung Park, who presented the study, evidence suggests that optimal medical therapy is a reasonable initial treatment strategy for chronic total occlusion, when compared with angioplasty. &nbsp; Critics<a href="https://solaci.org/en/2017/04/08/decision-cto-prevailing-questions-on-cto-rechanneling/" title="Read more" >...</a>

synergy vs XIENCE

SYNERGY vs. XIENCE in Complex Real-World Patients

Courtesy of Dr. Guillermo Migliaro. Technological advancements in drug-eluting stents (DES) have shown significant improvement as regards the safety and efficacy of these devices. DES are considered to be the golden standard for the treatment of percutaneous coronary interventions. &nbsp; DES with permanent or durable polymers (DP) have been associated with local inflammatory reactions and<a href="https://solaci.org/en/2017/04/01/synergy-vs-xience-in-complex-real-world-patients/" title="Read more" >...</a>

dispositivo de cierre manta en acceso femoral

MANTA Closure Device for large-bore arteriotomy closure: Is It Safe?

&nbsp;Courtesy of Dr.&nbsp;Agustín&nbsp;Vecchia.&nbsp; The number of transcatheter aortic valve replacements (TAVR) and the placement of aortic endoprosthesis and ventricular assist devices, among others, have grown exponentially worldwide in the last few years. In a short time, many of these procedures will surely become the new standard of care. Logically, this growth comes hand in hand<a href="https://solaci.org/en/2017/03/27/manta-closure-device-for-large-bore-arteriotomy-closure-is-it-safe/" title="Read more" >...</a>

Isquemia crítica de miembros inferiores: el blush de la herida

Critical Limb Ischemia: Wound Blush Is the Most Important Objective

The aim of this study was to find the optimal angiographic endpoint for infrapopliteal interventions to be able to predict wound healing. &nbsp; Evidence shows acceptable patency and successful limb salvage in patients with critical limb ischemia after infrapopliteal intervention. However, the optimal angiographic endpoint remains unclear. Is it enough to restore flow in one<a href="https://solaci.org/en/2017/03/10/critical-limb-ischemia-wound-blush-is-the-most-important-objective/" title="Read more" >...</a>

acceso radial oclusiones totales crónicas

Is The Transradial Approach Useful in CTO?

Courtesy of Dr. Carlos Fava. The transradial approach has been advanced in time, and is being increasingly used in more and more complex angioplasty procedures with the same benefit, compared to the classical femoral approach. As a result, in many high volume centers, this reality has demoted the femoral approach to a few particular procedures.<a href="https://solaci.org/en/2017/02/25/is-the-transradial-approach-useful-in-cto/" title="Read more" >...</a>

Top